These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24500123)

  • 1. The use of prescription opioid medication by patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study.
    Frankenburg FR; Fitzmaurice GM; Zanarini MC
    J Clin Psychiatry; 2014 Apr; 75(4):357-61. PubMed ID: 24500123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study.
    Zanarini MC; Frankenburg FR; Reich DB; Fitzmaurice G
    Am J Psychiatry; 2012 May; 169(5):476-83. PubMed ID: 22737693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study.
    Zanarini MC; Frankenburg FR; Weingeroff JL; Reich DB; Fitzmaurice GM; Weiss RD
    Addiction; 2011 Feb; 106(2):342-8. PubMed ID: 21083831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder.
    Zanarini MC; Frankenburg FR; Hennen J; Silk KR
    Am J Psychiatry; 2003 Feb; 160(2):274-83. PubMed ID: 12562573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult experiences of abuse reported by borderline patients and Axis II comparison subjects over six years of prospective follow-up.
    Zanarini MC; Frankenburg FR; Reich DB; Hennen J; Silk KR
    J Nerv Ment Dis; 2005 Jun; 193(6):412-6. PubMed ID: 15920382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history study of the familial coaggregation of borderline personality disorder with axis I and nonborderline dramatic cluster axis II disorders.
    Zanarini MC; Barison LK; Frankenburg FR; Reich DB; Hudson JI
    J Pers Disord; 2009 Aug; 23(4):357-69. PubMed ID: 19663656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization.
    Frankenburg FR; Zanarini MC
    J Clin Psychiatry; 2004 Dec; 65(12):1660-5. PubMed ID: 15641871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission.
    Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
    Am J Psychiatry; 2004 Nov; 161(11):2108-14. PubMed ID: 15514413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study.
    Zanarini MC; Frankenburg FR; Reich DB; Silk KR; Hudson JI; McSweeney LB
    Am J Psychiatry; 2007 Jun; 164(6):929-35. PubMed ID: 17541053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years.
    Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
    J Pers Disord; 2005 Feb; 19(1):19-29. PubMed ID: 15899718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission.
    Zanarini MC; Frankenburg FR; Vujanovic AA; Hennen J; Reich DB; Silk KR
    Acta Psychiatr Scand; 2004 Dec; 110(6):416-20. PubMed ID: 15521825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive experiences reported by patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study.
    Zanarini MC; Frankenburg FR; Wedig MM; Fitzmaurice GM
    Am J Psychiatry; 2013 Jun; 170(6):671-9. PubMed ID: 23558452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years.
    Zanarini MC; Frankenburg FR; Hennen J; Silk KR
    J Clin Psychiatry; 2004 Jan; 65(1):28-36. PubMed ID: 14744165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the 10-year course of borderline personality disorder.
    Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
    Am J Psychiatry; 2006 May; 163(5):827-32. PubMed ID: 16648323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 10-year course of adult aggression toward others in patients with borderline personality disorder and axis II comparison subjects.
    Zanarini MC; Temes CM; Ivey AM; Cohn DM; Conkey LC; Frankenburg FR; Fitzmaurice GM
    Psychiatry Res; 2017 Jun; 252():134-138. PubMed ID: 28264784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axis I comorbidity of borderline personality disorder.
    Zanarini MC; Frankenburg FR; Dubo ED; Sickel AE; Trikha A; Levin A; Reynolds V
    Am J Psychiatry; 1998 Dec; 155(12):1733-9. PubMed ID: 9842784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course of adult experiences of abuse in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study.
    McGowan A; King H; Frankenburg FR; Fitzmaurice G; Zanarini MC
    J Pers Disord; 2012 Apr; 26(2):192-202. PubMed ID: 22486449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defense mechanisms reported by patients with borderline personality disorder and axis II comparison subjects over 16 years of prospective follow-up: description and prediction of recovery.
    Zanarini MC; Frankenburg FR; Fitzmaurice G
    Am J Psychiatry; 2013 Jan; 170(1):111-20. PubMed ID: 23223866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borderline personality disorder features and risk for prescription opioid use disorders.
    Tragesser SL; Jones RE; Robinson RJ; Stutler A; Stewart A
    J Pers Disord; 2013 Aug; 27(4):427-41. PubMed ID: 23718741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motives for opioid use explain the relation between borderline personality disorder pathology and opioid use problems.
    Scamaldo KM; Tull MT; Gratz KL
    Psychiatry Res; 2021 Feb; 296():113609. PubMed ID: 33418458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.